These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [A clinical evaluation of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Author: Nagata M.
    Journal: Arerugi; 1998 Apr; 47(4):426-33. PubMed ID: 9621470.
    Abstract:
    Clustered immunotherapy (C-IT) using house-dust (HD) antigen was performed in eight HD-mite-sensitive adult bronchial asthmatics. Six mg of mequitazine was given 2 hours before each visit. For each visit, injections of antigen were performed four times with an hour interval. Either 0.1 ml of 10-fold concentration of the HD or a final dose at the end of the fifth week was determined as a maintenance dose. All cases have reached to ten-fold concentration of the HD antigen within 5 weeks and been able to introduce maintenance therapy without any systemic reaction. Following C-IT, a rapid increase in morning peak expiratory flow rate was observed which is followed by decrease in clinical scores. Furthermore, an increase in mite-specific IgG4 antibody and a decrease in peripheral blood eosinophils were observed 16 weeks following C-IT. These results suggest that C-IT using HD antigen can be performed safely and securely and provides rapid immunological responses as well as clinical benefit in HD-mite-sensitive adult asthmatics.
    [Abstract] [Full Text] [Related] [New Search]